Covered recipient · General Payments record
FREDERICK NIEGOS
Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism
General Payments · PY2018–2024
$7,959.22
- Reported across 470 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $603.96 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $147.88 | 10 |
| Ascensia Diabetes Care US Inc. | $127.53 | 1 |
| Medtronic, Inc. | $72.78 | 2 |
| Lilly USA, LLC | $63.94 | 2 |
| Tandem Diabetes Care, Inc. | $53.35 | 2 |
| Amgen Inc. | $37.43 | 2 |
| DEXCOM, INC. | $28.44 | 1 |
| BETA BIONICS, INC. | $22.34 | 1 |
| VIVUS LLC | $22.10 | 1 |
| Xeris Pharmaceuticals, Inc. | $14.66 | 1 |
| Averitas Pharma Inc. | $13.51 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.28 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111662645 | CMS |
| Amgen Inc. | $22.15 | 09/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117641973 | CMS |
| Ascensia Diabetes Care Us Inc. | $127.53 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089093459 | CMS |
| Averitas Pharma Inc. | $13.51 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133439006 | CMS |
| BETA BIONICS, INC. | $22.34 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087888029 | CMS |
| Dexcom, Inc. | $28.44 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153300686 | CMS |
| Lilly USA, LLC | $30.95 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134992062 | CMS |
| Lilly USA, LLC | $32.99 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134981156 | CMS |
| Medtronic, Inc. | $33.34 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119415676 | CMS |
| Medtronic, Inc. | $39.44 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119415678 | CMS |
| Novo Nordisk Inc | $23.14 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096757121 | CMS |
| Novo Nordisk Inc | $22.83 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097361739 | CMS |
| Novo Nordisk Inc | $5.54 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096750051 | CMS |
| Novo Nordisk Inc | $23.38 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096600705 | CMS |
| Novo Nordisk Inc | $6.12 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097310932 | CMS |
| Novo Nordisk Inc | $17.56 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096589566 | CMS |
| Novo Nordisk Inc | $9.58 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097484343 | CMS |
| Novo Nordisk Inc | $9.15 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097236176 | CMS |
| Novo Nordisk Inc | $25.49 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096593582 | CMS |
| Novo Nordisk Inc | $5.09 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097589923 | CMS |
| Tandem Diabetes Care, Inc. | $27.83 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138746063 | CMS |
| Tandem Diabetes Care, Inc. | $25.52 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1138746049 | CMS |
| VIVUS LLC | $22.10 | 02/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1129417335 | CMS |
| Xeris Pharmaceuticals, Inc. | $14.66 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144595030 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.